2025.11. 10 本文字数：3193，阅读时长大约5分钟 尽管整体收益有所回落，但头部产品的表现依旧亮眼。从具体产品来看，永赢科技智选A以 205.35%的年内表现大幅领跑，与第二名拉开了近58个百分点；恒越优势精选、红土创新新兴产业 分别以147.36%、139.82%的年内回报位居第二、第三。此外，还有中欧数字经济A、中航机遇领 航A等36只产品业绩实现翻倍。 作者 | 第一财经 曹璐 临近年底，A股在4000点关口的震荡盘整节奏中，主动权益基金正迎来年度业绩冲刺的关键节点。 市场结构显著分化，"高切低"特征下，基金业绩首尾差距已惊人地超过220个百分点，领跑者收益 率突破200%，而垫底产品仍在负收益中挣扎。 在这个关键冲刺阶段，多家基金公司对旗下产品"流量阀"进行动态调控。一边是部分绩优基金果断 放开大额申购，积极"补弹药"；另一边，也有众多产品反其道而行，将申购门槛严控至万元甚至百 元级别。 这一收一放之间，既是基金公司对后市机遇的预判，也有主动管理规模、稳定业绩的考量。站在当前 时点，多位业内受访人士表示，对后续权益市场表现保持积极乐观，并建议以均衡风格应对市场的快 速轮动，短期调整之际或也 ...

Core Insights - The A-share market is experiencing significant structural differentiation, with a performance gap exceeding 220 percentage points between top and bottom-performing funds, highlighting a "high-cut low" characteristic [1][3] - Many fund companies are dynamically adjusting their subscription policies, with some high-performing funds lifting restrictions on large subscriptions while others are tightening limits to manage performance and scale [1][5] Market Performance - As of November 10, the A-share market is fluctuating around the 4000-point mark, with the Shanghai Composite Index showing a year-to-date increase of 19.9% [2] - The average return of actively managed equity funds has decreased from 33.08% at the end of Q3 to 30.51% [2][3] Fund Performance - Top-performing funds include Yongying Technology Smart A with a return of 205.35%, followed by Hengyue Advantage Selection at 147.36% and Hongtu Innovation Emerging Industry at 139.82% [3][4] - There are currently 147 actively managed equity funds struggling with negative returns, with some experiencing declines exceeding 10% [3] Subscription Policy Adjustments - Several funds have lifted restrictions on large subscriptions, including E Fund Rui Xiang Mixed and Changcheng Medical Industry Selection, to meet investor demand [5][6] - Conversely, 218 actively managed equity funds have suspended large subscriptions, with some limiting daily subscription amounts to as low as 100 yuan [7][8] Market Outlook - The market is expected to maintain a slow bull trend in Q4, with recommendations for balanced investment strategies across various sectors [8][9] - The innovation drug sector is facing volatility due to a mismatch between market expectations and actual industry developments, with a shift in focus from short-term event-driven trading to long-term fundamental performance [9]

业绩翻倍不是终点，而是起点，未来，红土创新基金将秉承发现并追求价值成长的理念，持续提升投资 者获得感！ 风险提示：本材料提及的看法和思路仅代表发表时的观点，随着市场环境变化可能会发生改变，故不构 成任何投资建议或保证；本材料提及的关于投资范围、投资方向、投资比例等内容不构成产品投资操作 的限制，产品的投资范围、投资策略、投资限制以产品合同约定为准。本材料不作为任何法律文件。我 国基金运作时间较短，不能反映股市、债市发展的所有阶段。基金的过往业绩并不代表未来表现，基金 管理人管理的其他基金的业绩并不构成基金业绩的表现保证。基金投资有风险，请投资者全面认识基金 的风险特征，听取销售机构的适当性意见，根据自身风险承受能力，在详细阅读《基金合同》、《招募 说明书》及《产品资料概要》等文件基础上，谨慎投资。请投资者严格遵守反洗钱相关法律法规的规 定，切实履行反洗钱义务。基金有风险，投资须谨慎。 亮眼成绩单的背后，是红土创新基金专业投研能力的深度沉淀与产品策略的持续优化。公司依托产研投 一体化平台，构建了一支深度融合宏观研究、行业分析与个股挖掘的投研团队。通过科学的资产配置策 略，各产品精准捕捉市场机遇，在不同风格与周期 ...

Core Insights - The A-share market has shown significant recovery in 2025, with the Shanghai Composite Index reaching a 10-year high of 4025.70 points by the end of October, leading to a strong performance of public equity funds and the emergence of numerous "doubling funds" [1][3] Group 1: Fund Performance - The average net value growth rate of actively managed equity funds for the first ten months reached 27.48%, with the best-performing funds exceeding 200% [3][5] - Over 98% of actively managed equity funds reported positive net value growth rates, with 705 funds achieving over 50% growth, and 34 funds surpassing 100% [7][5] - The top-performing fund, Yongying Technology Smart Selection A, achieved a net value growth rate of 200.63%, capitalizing on opportunities in the cloud computing market [9][8] Group 2: Index and Sector Performance - Major indices such as the ChiNext Index and the Science and Technology Innovation 50 Index saw annual growth rates exceeding 50%, with the ChiNext Index at 48.84% [1][4] - The communication equipment sector emerged as a significant winner, with related index funds showing remarkable performance, including the Guotai CSI All-Index Communication Equipment ETF, which had a growth rate of 98.87% [12][13] Group 3: Investment Themes and Manager Insights - Fund managers are focusing on structural opportunities in sectors like AI, innovative drugs, and robotics, which have shown strong performance [7][14] - Investment strategies include a focus on domestic semiconductor equipment and energy storage, with managers highlighting the increasing production capacity of domestic storage chips and the growing demand for energy storage solutions [15][14]

Group 1 - The core viewpoint of the articles highlights the strong performance of public funds in 2023, with 60 funds achieving a net value growth rate exceeding 100%, led by Yongying Technology Smart Selection A at 223.81% [1] - The top-performing funds are primarily focused on technology innovation, particularly in sectors like artificial intelligence, semiconductors, and cloud computing, indicating a high concentration in these areas [1][2] - Fund managers express optimism about the long-term investment opportunities in the technology growth sector, particularly as the global AI industry accelerates its commercialization [1][2] Group 2 - Yongying Technology Smart Selection Fund maintains a high allocation in the cloud computing supply chain, particularly in optical communication and printed circuit boards, reflecting a strong belief in the computing power industry [1] - The fund's top ten holdings are concentrated in the communication and electronics sectors, including leading companies in optical modules and electronic enterprises, showcasing a commitment to the computing power supply chain [1] - Other funds, such as Huatai-PineBridge Hong Kong Advantage Selection A, have also performed well by focusing on the Hong Kong stock market, achieving a net value growth rate of 123.37% [2] Group 3 - Fund managers believe that the technology growth sector will continue to present investment opportunities, with a rich array of configuration solutions emerging in computing, communication, and storage [2][3] - The CPO and PCB industries are expected to see significant technological advancements by 2027, marking a pivotal year for new technology convergence [2] - The impressive performance of funds like China Europe Digital Economy A is attributed to their deep investments in the AI industry chain, focusing on five core investment directions [2]

Group 1: Market Performance - The A-share market has shown strong performance this year, with the Shanghai Composite Index rising by 19.25%, the Shenzhen Component Index by 29.52%, and the ChiNext Index by 51.03% as of October 27 [1][2] - The Hang Seng Index and the Hang Seng Technology Index have also increased by 31.77% and 38.11% respectively [1] - Over 30 equity funds have doubled their returns this year, with some funds achieving over 100% returns [2] Group 2: Fund Performance and Strategy - The average return for over 1,000 ordinary stock funds is 31.21%, with a median return of 29.01% [2] - Notable funds like Yongying Technology Select A have reported a return of 206.10% year-to-date, while others like China Europe Digital Economy A have achieved 138.72% [3][4] - Fund managers are advising investors to diversify their investments to mitigate risks associated with high valuations in the AI sector [4] Group 3: Sector Insights - The technology sector, particularly companies involved in optical packaging, has been a significant contributor to fund performance [3] - The CPO index has seen a rise of over 100% this year, indicating strong growth in this segment [3] - The healthcare sector has shown mixed results, with some funds underperforming despite a previous uptrend in the medical index [5] Group 4: Fund Manager Insights - Fund managers are increasingly cautious about the high valuations in the AI sector, suggesting that some stocks may be overvalued based on optimistic growth expectations [4] - There is a call for a balanced approach in asset allocation, emphasizing the importance of not concentrating investments in a single sector [4][5] - The healthcare sector is undergoing a rationalization phase, with funds adjusting their portfolios to include a mix of innovative and generic drugs [5] Group 5: Research and Analysis Trends - Public funds are intensifying their research efforts during the earnings report season, with a significant increase in the number of companies being surveyed [6][7] - The pharmaceutical and biotechnology sectors are receiving the most attention from public fund managers, indicating a focus on validating company performance and growth potential [6][7]

Group 1 - The core point of the article highlights a significant decline in the number of "doubling funds" in the A-share market, with over half disappearing in less than ten trading days due to high volatility and corrections in leading sectors like innovative pharmaceuticals and technology [1][2] - As of October 21, only 25 funds with a cumulative increase of over 100% remained, a sharp drop from 53 at the end of September, indicating a substantial contraction in the "doubling fund" category [2][3] - The innovative pharmaceutical index and the Hong Kong Stock Connect innovative pharmaceutical index have seen declines of 9.17% and 11.59% respectively since October, with both indices retreating over 13% from their yearly highs [2][3] Group 2 - Despite the recent corrections, funds focused on technology and pharmaceuticals still dominate, with top performers like Yongying Technology Smart A achieving a 194.96% annual return [3][4] - The number of "doubling funds" fluctuated dramatically, reaching a low of just 8 on October 14, but rebounded as the technology sector showed signs of recovery [3][4] - Recent inflows into pharmaceutical ETFs indicate continued investor interest, with significant net inflows recorded for several funds since the beginning of October [3][5] Group 3 - Analysts suggest that the recent market adjustments may provide better investment opportunities, as the corrections are seen as a release of risk rather than a long-term trend [5][6] - The shift in market style from growth to value is attributed to factors such as U.S.-China trade tensions and profit-taking by investors after substantial gains in technology stocks [6][7] - The long-term outlook for innovative pharmaceuticals remains positive, with expectations of continued growth driven by successful business development and clinical advancements [7][8]

Core Viewpoint - The A-share and Hong Kong stock markets have shown a continuous upward trend since mid-April, achieving new highs in the third quarter, with equity funds yielding significant returns [1] Group 1: Active Equity Funds - A total of 37 funds have doubled their returns this year as of September 26, with 31 active equity funds in A-shares achieving over 100% returns [2][4] - The average return for active equity funds is 30.32%, with over 98% of these funds reporting positive returns [4] - The top-performing fund, Yongying Technology Smart Selection A, has a return rate of 189.58%, significantly boosted by its focus on AI concept stocks [4][6] Group 2: Passive Index Funds - Nearly 98% of index funds have achieved positive returns, with an average return of 27.53% [7] - Funds tracking innovative drugs, communications, and artificial intelligence have outperformed, with the top two funds yielding returns of 103.96% and 100.59% [7] - Underperforming index funds are primarily those tracking energy, food and beverage, and coal sectors, with losses exceeding 5% [7] Group 3: QDII Funds - QDII funds focused on the Hong Kong market, particularly in innovative drug assets, have performed well, with four funds exceeding 100% returns [3][8] - The top-performing QDII fund, Huatai Bairui Hang Seng Innovation Drug ETF, has a return of 152.25% [8] - Other notable funds in this category have also shown strong performance, with several exceeding 90% returns [8]

Core Insights - The performance of actively managed equity funds has significantly rebounded, particularly among small and medium-sized public funds, marking a shift from the dominance of larger funds in the market [1][2] - The resurgence in performance is attributed to a combination of market trends and competitive dynamics within the industry, with smaller funds demonstrating agility in adjusting their portfolios to capture market opportunities [6][9] Performance Highlights - Since September 24 of the previous year, the average net asset value growth rate for actively managed equity funds reached 40.77%, with 245 funds doubling their net value [2] - Among these "doubling funds," 133 are from small and medium-sized public funds, accounting for 54.3% of the total [2][6] - The top-performing funds include CITIC Securities' North Exchange Selected Two-Year Open A with a growth rate of 240.22%, and Debon Xin Xing Value A with a 221.47% increase [3] Competitive Landscape - A total of 245 "doubling funds" are managed by 77 different fund companies, with notable contributions from firms like Caitong Fund and E Fund [6] - The competitive advantage of smaller funds lies in their ability to quickly adjust their holdings and focus on high-growth sectors, unlike larger firms that face constraints due to their size [6][9] Investment Strategies - The trend towards "track-based" and "high-sharp" investment strategies among small public funds has become more pronounced, allowing for clearer style positioning and better performance predictability [8] - However, there is a caution against "betting-style" investments that may arise from focusing solely on specific sectors without adequate diversification [7][9] Future Outlook - The macroeconomic environment is expected to maintain a weak recovery, with a likelihood of continued focus on technology-driven growth in the stock market [9] - If there is an unexpected recovery in infrastructure, consumption, and investment sectors, larger equity funds may also see performance opportunities [9] - Long-term value creation and strengthening research capabilities remain essential for sustainable growth across both small and large fund management firms [9]

Core Viewpoint - The performance of actively managed equity funds has significantly rebounded, with small and medium-sized public funds showing remarkable improvement, marking a shift from the dominance of larger funds in the market [2][4]. Group 1: Market Performance - Since September 24 of last year, major A-share indices have risen sharply, leading to an average net value growth rate of 40.77% for actively managed equity funds, with 245 funds doubling their net value [4]. - Among the "doubling funds," 133 are from small and medium-sized public funds, accounting for 54.3% of the total [4]. Group 2: Fund Performance Highlights - The top-performing funds include: - CITIC Securities North Exchange Selection Two-Year Open A with a growth rate of 240.22% - Debon Xin Xing Value A at 221.47% - Yongying Advanced Manufacturing Smart Selection A at 205.63% - Other notable funds include Xin Ao Performance Driven A and Zhonghang Opportunity Navigation A, both exceeding 197% growth [5]. Group 3: Industry Dynamics - The success of small and medium-sized public funds is attributed to their ability to quickly adapt to market opportunities due to their smaller scale, allowing for more flexible portfolio adjustments compared to larger firms [6]. - The structural market conditions have favored small-cap stocks, which have seen significant price increases, benefiting smaller funds that can concentrate their holdings in these areas [6]. Group 4: Investment Strategies - The trend towards "track-oriented" and "high sharpness" strategies among small and medium-sized public funds has become more pronounced, allowing for clearer investment style positioning and potentially higher alpha returns for investors [8]. - However, there is a caution against "betting-style" investments that focus solely on specific sectors without a diversified approach [9]. Group 5: Future Outlook - The macroeconomic environment is expected to maintain a weak recovery, with liquidity remaining relatively abundant, suggesting that the stock market will likely continue to favor technology growth styles [9]. - If there is an unexpected recovery in infrastructure, consumption, and investment sectors by mid-next year, larger equity funds may also see performance opportunities [9]. Group 6: Long-term Perspective - The recent performance surge of small and medium-sized public funds is viewed as a temporary outcome of specific market conditions, emphasizing the importance of long-term value creation and robust research capabilities for sustainable growth [9].